Roche upbeat on Avastin in ovarian cancer (Reuters)
Reuters – Roche Holding AG, the world’s leader in oncology drugs, struck an upbeat tone about approval prospects for its key drug Avastin in ovarian cancer ahead of an important industry meeting next month.
View full post on Yahoo! News: Health News
Leave a Reply